Sugammadex Reduces PACU Recovery Time after Abdominal Surgery Compared with Neostigmine.

Authors

Jin Deng
Maha Balouch
Michael Albrink
Enrico M Camporesi

Publication/Presentation Date

10-1-2021

Abstract

OBJECTIVE: This study blindly evaluated sugammadex compared with neostigmine on length of stay in the postanesthesia care unit (PACU).

METHODS: Fifty patients undergoing elective laparoscopic cholecystectomy or abdominal wall hernia repair consented to receive either sugammadex (2 mg/kg) or neostigmine (0.07 mg/kg) for the reversal of rocuronium neuromuscular blockade. Reversal agents were administered during surgical closing, and the train of four was measured until a twitch ratio of T4:T1 ≥ 0.9 was obtained to signify a robust reversal. Postreversal outcomes also were measured during PACU stay. Aldrete scores, pain visual analog scale score, and nausea were measured during the PACU stay.

RESULTS: Patients receiving sugammadex experienced a shorter PACU stay at the time of discharge than patients receiving neostigmine, by an average of 12 minutes (

CONCLUSIONS: Sugammadex patients had a significantly shorter PACU stay.

Volume

114

Issue

10

First Page

644

Last Page

648

ISSN

1541-8243

Published In/Presented At

Deng, J., Balouch, M., Albrink, M., & Camporesi, E. M. (2021). Sugammadex Reduces PACU Recovery Time after Abdominal Surgery Compared with Neostigmine. Southern medical journal, 114(10), 644–648. https://doi.org/10.14423/SMJ.0000000000001304

Disciplines

Medical Education | Medicine and Health Sciences

PubMedID

34599343

Department(s)

USF-LVHN SELECT Program

Document Type

Article